Daré Bioscience Announces Executive Team and Board of
SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced changes in...
Source: globenewswire.com
Stay updated with breaking news from Simona Kormanikova. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced changes in...
SAN DIEGO, Dec. 26, 2023 -- Daré Bioscience, Inc. , a leader in women’s health innovation, today announced it has entered into a royalty-backed financing agreement that provides Daré with $5...
DARE-PTB1 is being developed as a treatment to reduce the risk of preterm birth, for which there are no FDA-approved treatment options Up to approximately $2 million in grant funding to support DARE-PTB1 Phase 1 human